Cargando…
Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection
BACKGROUND: IgA nephropathy (IgAN) is the most frequent glomerulonephritis in many countries including Estonia. There is no specific treatment for IgAN but renoprotection is indicated when proteinuria is >1 g/day. We aimed to assess the clinicopathological correlations of IgAN and to compare the...
Autores principales: | Riispere, Živile, Kuudeberg, Anne, Seppet, Elviira, Sepp, Kristin, Ilmoja, Madis, Luman, Merike, Kõlvald, Külli, Auerbach, Asta, Ots-Rosenberg, Mai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351168/ https://www.ncbi.nlm.nih.gov/pubmed/28292274 http://dx.doi.org/10.1186/s12882-017-0499-4 |
Ejemplares similares
-
Improvements in Renal Replacement Therapy Practice Patterns in Estonia
por: Kõlvald, Külli, et al.
Publicado: (2014) -
Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014) -
Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy
por: Horita, Yoshio, et al.
Publicado: (2007) -
The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019) -
IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)